175 related articles for article (PubMed ID: 23541566)
1. Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project.
van der Zwan JM; Trama A; Otter R; Larrañaga N; Tavilla A; Marcos-Gragera R; Dei Tos AP; Baudin E; Poston G; Links T;
Eur J Cancer; 2013 Jul; 49(11):2565-78. PubMed ID: 23541566
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma of endocrine organs: results of the RARECARE project.
van der Zwan JM; Mallone S; van Dijk B; Bielska-Lasota M; Otter R; Foschi R; Baudin E; Links TP;
Eur J Cancer; 2012 Sep; 48(13):1923-31. PubMed ID: 22361014
[TBL] [Abstract][Full Text] [Related]
4. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.
Mallone S; De Vries E; Guzzo M; Midena E; Verne J; Coebergh JW; Marcos-Gragera R; Ardanaz E; Martinez R; Chirlaque MD; Navarro C; Virgili G;
Eur J Cancer; 2012 May; 48(8):1167-75. PubMed ID: 22119735
[TBL] [Abstract][Full Text] [Related]
5. Rare cancers are not so rare: the rare cancer burden in Europe.
Gatta G; van der Zwan JM; Casali PG; Siesling S; Dei Tos AP; Kunkler I; Otter R; Licitra L; Mallone S; Tavilla A; Trama A; Capocaccia R;
Eur J Cancer; 2011 Nov; 47(17):2493-511. PubMed ID: 22033323
[TBL] [Abstract][Full Text] [Related]
6. Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project.
Mallone S; De Angelis R; van der Zwan JM; Trama A; Siesling S; Gatta G; Capocaccia R;
Cancer Epidemiol; 2013 Dec; 37(6):850-6. PubMed ID: 24050903
[TBL] [Abstract][Full Text] [Related]
7. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe.
Trama A; Mallone S; Nicolai N; Necchi A; Schaapveld M; Gietema J; Znaor A; Ardanaz E; Berrino F;
Eur J Cancer; 2012 Jan; 48(2):159-69. PubMed ID: 22142457
[TBL] [Abstract][Full Text] [Related]
8. Rare cancers of the head and neck area in Europe.
Van Dijk BA; Gatta G; Capocaccia R; Pierannunzio D; Strojan P; Licitra L;
Eur J Cancer; 2012 Apr; 48(6):783-96. PubMed ID: 22051735
[TBL] [Abstract][Full Text] [Related]
9. Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources.
Darbà J; Marsà A
BMC Cancer; 2019 Dec; 19(1):1226. PubMed ID: 31842791
[TBL] [Abstract][Full Text] [Related]
10. Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.
Navalkele P; O'Dorisio MS; O'Dorisio TM; Zamba GK; Lynch CF
Pediatr Blood Cancer; 2011 Jan; 56(1):50-7. PubMed ID: 21108439
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia.
Wyld D; Wan MH; Moore J; Dunn N; Youl P
Cancer Epidemiol; 2019 Dec; 63():101598. PubMed ID: 31539715
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of glial and non-glial brain tumours in Europe.
Crocetti E; Trama A; Stiller C; Caldarella A; Soffietti R; Jaal J; Weber DC; Ricardi U; Slowinski J; Brandes A;
Eur J Cancer; 2012 Jul; 48(10):1532-42. PubMed ID: 22227039
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of rare cancers and inequalities in oncologic outcomes.
Gatta G; Trama A; Capocaccia R;
Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924
[TBL] [Abstract][Full Text] [Related]
14. Rare thoracic cancers, including peritoneum mesothelioma.
Siesling S; van der Zwan JM; Izarzugaza I; Jaal J; Treasure T; Foschi R; Ricardi U; Groen H; Tavilla A; Ardanaz E;
Eur J Cancer; 2012 May; 48(7):949-60. PubMed ID: 22406029
[TBL] [Abstract][Full Text] [Related]
15. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
Gatta G; Capocaccia R; Botta L; Mallone S; De Angelis R; Ardanaz E; Comber H; Dimitrova N; Leinonen MK; Siesling S; van der Zwan JM; Van Eycken L; Visser O; Žakelj MP; Anderson LA; Bella F; Kaire I; Otter R; Stiller CA; Trama A;
Lancet Oncol; 2017 Aug; 18(8):1022-1039. PubMed ID: 28687376
[TBL] [Abstract][Full Text] [Related]
16. The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project.
Trama A; Mallone S; Ferretti S; Meduri F; Capocaccia R; Gatta G;
Tumori; 2012; 98(5):550-8. PubMed ID: 23235748
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004.
Alsina M; Marcos-Gragera R; Capdevila J; Buxó M; Ortiz RM; Barretina P; Vilardell L; Brunet J; Beltran M; Izquierdo Á
Cancer Epidemiol; 2011 Dec; 35(6):e49-54. PubMed ID: 21840785
[TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
19. Embryonal cancers in Europe.
Gatta G; Ferrari A; Stiller CA; Pastore G; Bisogno G; Trama A; Capocaccia R;
Eur J Cancer; 2012 Jul; 48(10):1425-33. PubMed ID: 22357215
[TBL] [Abstract][Full Text] [Related]
20. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project.
Stiller CA; Trama A; Serraino D; Rossi S; Navarro C; Chirlaque MD; Casali PG;
Eur J Cancer; 2013 Feb; 49(3):684-95. PubMed ID: 23079473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]